Oct 8, 2018 Ethnic disparities seen in FDA pathway 'Exception From Informed Consent' trials Ethnic disparities seen in FDA pathway ‘Exception From Informed Consent’ trialsMany of the interventions tested were associated with adverse events, including higher mortality, neurological impairment, and myocardial infarction. ... read morePublished on 2018-10-08